President Trump’s announcement of new tariffs on semiconductors and pharmaceuticals kept markets in flux. Plus: Drugmaker Pfizer boosted its annual profit guidance. And, data-software company Palantir ...

The Department of Health and Human Services plans to cancel contracts and pull funding for some vaccines being developed to ...

The S&P 500 ended lower on Tuesday as unexpected weakness in U.S. services sector data raised fresh concerns about the ...

The US Department of Health and Human Services is ending contracts to develop vaccines using messenger RNA technology, ...

Pfizer stock rose after the drugmaker posted adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, ...

Q2 2025 Earnings Conference Call August 5, 2025 10:00 AM ETCompany ParticipantsAamir Malik - Corporate ParticipantAlbert Bourla ...

Live Updates Live Coverage Updates appear automatically as they are published. Investors Don't Like the Taste of Yum! 9:37 am ...

In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both ...

Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...

President Donald Trump said his administration is prepared to increase the tariffs it plans to impose on pharmaceuticals up ...

Most of its precision oncology products, including Lorbrena, Braftovi, Mektovi, and Talzenna, posted double-digit increases ...

Bourla, who took over as CEO in 2019, has declined to say how long he intends to remain in his role at Pfizer. Developing a ...